Literature DB >> 12717263

Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome.

Ichiro Watanabe1, Takahiro Hasebe, Satoshi Sasaki, Masaru Konishi, Kazuto Inoue, Toshio Nakagohri, Tatsuya Oda, Kiyoshi Mukai, Taira Kinoshita.   

Abstract

INTRODUCTION: Many investigators have examined prognostic factors for advanced pancreatic ductal cancer, but it is still difficult to accurately predict the outcome of the disease. AIM: To examine correlation between histopathologic factors and outcome of advanced ductal carcinoma of the pancreas.
METHODOLOGY: The subjects were 23 patients who underwent resection of pancreatic ductal cancer classified as stage III according to pTNM classification. Fibrotic focus (which is evidence of intratumoral fibroblast proliferation), tumor size and differentiation, invasion to the portal vein, and immunohistologic expression of E-cadherin and alpha-, beta- andbgr;- and gamma-catenins were evaluated. Correlation between histologic and immunohistologic data and correlation between these data and liver metastasis-free survival and overall survival were assessed by means of the Kaplan-Meier method, the log-rank test, and the Cox proportional hazards regression model (for multivariate analysis).
RESULTS: The presence of fibrotic focus correlated with reduced membranous beta-catenin expression. The presence of fibrotic focus, reduced membranous beta-catenin expression, and reduced cytoplasmic alpha-catenin expression were significantly associated with shorter liver metastasis-free survival. The presence of fibrotic focus also significantly correlated with shorter survival and was the only factor significantly associated with survival in multivariate analysis.
CONCLUSION: The presence of fibrotic focus and reduced beta-catenin expression closely correlated with poor survival of patients with advanced ductal carcinoma of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717263     DOI: 10.1097/00006676-200305000-00003

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  27 in total

1.  Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Authors:  Kwang Yeol Paik; Seong Ho Choi; Jin Seok Heo; Dong Wook Choi
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Ellagic acid and embelin affect key cellular components of pancreatic adenocarcinoma, cancer, and stellate cells.

Authors:  Mouad Edderkaoui; Aurelia Lugea; Hongxiang Hui; Guido Eibl; Qing-Yi Lu; Aune Moro; Xuyang Lu; Gang Li; Vay-Liang Go; Stephen J Pandol
Journal:  Nutr Cancer       Date:  2013-10-15       Impact factor: 2.900

4.  Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance.

Authors:  Min Shi; Dang-Hui Yu; Ying Chen; Chen-Yan Zhao; Jing Zhang; Qing-Hua Liu; Can-Rong Ni; Ming-Hua Zhu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 5.  Genomics of pancreatic cancer: does it make any improvement in diagnosis, prognosis and therapy?

Authors:  László Kopper; Attila Zalatnai; József Tímár
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

6.  Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.

Authors:  Shelby Lennon; Ayman Oweida; Dallin Milner; Andy V Phan; Shilpa Bhatia; Benjamin Van Court; Laurel Darragh; Adam C Mueller; David Raben; Jorge L Martínez-Torrecuadrada; Todd M Pitts; Hilary Somerset; Kimberly R Jordan; Kirk C Hansen; Jason Williams; Wells A Messersmith; Richard D Schulick; Philip Owens; Karyn A Goodman; Sana D Karam
Journal:  Clin Cancer Res       Date:  2019-04-03       Impact factor: 12.531

Review 7.  The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment.

Authors:  Kelly J Lafaro; Laleh G Melstrom
Journal:  Am J Pathol       Date:  2019-01       Impact factor: 4.307

Review 8.  The burning question: why is smoking a risk factor for pancreatic cancer?

Authors:  Stephen J Pandol; Minoti V Apte; Jeremy S Wilson; Anna S Gukovskaya; Mouad Edderkaoui
Journal:  Pancreatology       Date:  2012-07-20       Impact factor: 3.996

Review 9.  Pancreatic cancer and its stroma: a conspiracy theory.

Authors:  Zhihong Xu; Srinivasa P Pothula; Jeremy S Wilson; Minoti V Apte
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 10.  Desmoplasia of pancreatic ductal adenocarcinoma.

Authors:  Stephen Pandol; Mouad Edderkaoui; Ilya Gukovsky; Aurelia Lugea; Anna Gukovskaya
Journal:  Clin Gastroenterol Hepatol       Date:  2009-11       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.